Suppr超能文献

肝细胞癌的治疗算法

Treatment algorithms for managing hepatocellular carcinoma.

作者信息

Saraswat Vivek A, Pandey Gaurav, Shetty Sachin

机构信息

Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.

出版信息

J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S80-9. doi: 10.1016/j.jceh.2014.05.004. Epub 2014 Jun 6.

Abstract

Early diagnosis and aggressive therapy improves outcome in hepatocellular carcinoma (HCC). Several potentially curative as well as palliative treatment options are available for patients. The choice of therapy is influenced by factors such as extent of tumor and severity of underlying liver dysfunction as well as availability of resources and of expertise. A systematic, algorithmic approach would ensure optimal therapy for each patient and is likely to improve outcomes. Even after receiving therapy for HCC, patients remain at risk for recurrent HCC as well as progression of underlying cirrhosis. Proper assessment and monitoring is needed for the underlying liver disease, which may progress to liver failure and have a major impact on long-term survival. Comprehensive care for patients with cirrhosis includes interventions such as antiviral therapy for HBV and HCV, abstention from alcohol, management of fatty liver disease, endoscopic surveillance and treatment for complications of portal hypertension and, if indicated, immunization against HAV and HBV. An algorithmic approach is useful for choosing the most appropriate treatment option for the individual patient from among the various options that are available. The general consensus is that the BCLC system should be preferred for staging HCC as it is useful in predicting outcomes and planning treatment. The BCLC system classifies patients with HCC into five categories: very early, early, intermediate, advanced, and terminal. It incorporates data on tumor status (number and size of nodules, vascular invasion, extra-hepatic spread), liver function (CTP status, presence of portal hypertension) and overall health status (constitutional symptoms, cancer symptoms, performance status). Treatment allocation according to sub-class of patients is a merit of the BCLC system; a few limitations have been noted, particularly with respect to patients with BCLC stage B and C disease. The treatment algorithm as per BCLC system is summarized in this review.

摘要

早期诊断和积极治疗可改善肝细胞癌(HCC)的预后。对于患者有几种潜在的治愈性以及姑息性治疗选择。治疗方案的选择受肿瘤范围、潜在肝功能障碍的严重程度以及资源和专业知识的可用性等因素影响。一种系统的、循算法的方法将确保为每位患者提供最佳治疗,并可能改善预后。即使接受了HCC治疗,患者仍有复发性HCC以及潜在肝硬化进展的风险。需要对潜在的肝脏疾病进行适当评估和监测,其可能进展为肝衰竭并对长期生存产生重大影响。对肝硬化患者的综合护理包括抗病毒治疗(针对HBV和HCV)、戒酒、脂肪肝疾病管理、内镜监测以及门静脉高压并发症的治疗,如有指征,还包括甲型肝炎和乙型肝炎免疫接种。循算法的方法有助于从各种可用选项中为个体患者选择最合适的治疗方案。普遍的共识是,BCLC系统应优先用于HCC分期,因为它有助于预测预后和规划治疗。BCLC系统将HCC患者分为五类:极早期、早期、中期、晚期和终末期。它纳入了肿瘤状态(结节数量和大小、血管侵犯、肝外转移)、肝功能(CTP状态、门静脉高压的存在)和总体健康状况(全身症状、癌症症状、体能状态)的数据。根据患者亚类进行治疗分配是BCLC系统的一个优点;也注意到了一些局限性,特别是对于BCLC B期和C期疾病的患者。本综述总结了根据BCLC系统的治疗算法。

相似文献

1
Treatment algorithms for managing hepatocellular carcinoma.
J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S80-9. doi: 10.1016/j.jceh.2014.05.004. Epub 2014 Jun 6.
2
Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
Chin Clin Oncol. 2023 Apr;12(2):17. doi: 10.21037/cco-22-119. Epub 2023 Apr 18.
4
Staging of hepatocellular carcinoma.
J Clin Exp Hepatol. 2014 Aug;4(Suppl 3):S74-9. doi: 10.1016/j.jceh.2014.03.045. Epub 2014 Jun 6.
5
Early Hepatocellular Carcinoma Treated by Radiofrequency Ablation-Mid- and Long-Term Outcomes.
J Clin Exp Hepatol. 2020 Nov-Dec;10(6):563-573. doi: 10.1016/j.jceh.2020.04.016. Epub 2020 May 4.
6
Validation and ranking of seven staging systems of hepatocellular carcinoma.
Oncol Lett. 2017 Jul;14(1):705-714. doi: 10.3892/ol.2017.6222. Epub 2017 May 22.
7
Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
World J Gastroenterol. 2015 Sep 28;21(36):10327-35. doi: 10.3748/wjg.v21.i36.10327.
8
Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Cochrane Database Syst Rev. 2017 Mar 28;3(3):CD011650. doi: 10.1002/14651858.CD011650.pub2.
10
Patients with Barcelona Clinic Liver Cancer Stages B and C Hepatocellular Carcinoma: Time for a Subclassification.
Liver Cancer. 2019 Mar;8(2):78-91. doi: 10.1159/000489791. Epub 2018 Jun 27.

引用本文的文献

1
GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma.
Clin Mol Hepatol. 2025 Feb 6. doi: 10.3350/cmh.2024.1038.
2
An In-depth Review on in the Management of Liver Health and Liver Cancer.
Anticancer Agents Med Chem. 2025;25(1):24-34. doi: 10.2174/0118715206307964240821051756.
5
Comparative Oncology: Management of Hepatic Neoplasia in Humans and Dogs.
Vet Sci. 2022 Sep 8;9(9):489. doi: 10.3390/vetsci9090489.
8
Clinical stages of recurrent hepatocellular carcinoma: A retrospective cohort study.
World J Clin Cases. 2021 Sep 26;9(27):8020-8026. doi: 10.12998/wjcc.v9.i27.8020.
9
Second-line treatments for Advanced Hepatocellular Carcinoma: A Systematic Review and Bayesian Network Meta-analysis.
Clin Exp Med. 2022 Feb;22(1):65-74. doi: 10.1007/s10238-021-00727-7. Epub 2021 Jun 19.

本文引用的文献

1
Liver Transplantation for HCC: A Review.
Indian J Surg. 2012 Feb;74(1):100-17. doi: 10.1007/s12262-011-0387-2. Epub 2011 Dec 27.
3
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
Hepatology. 2013 Apr;57(4):1426-35. doi: 10.1002/hep.25832. Epub 2013 Jan 25.
4
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
J Hepatol. 2012 Apr;56(4):908-43. doi: 10.1016/j.jhep.2011.12.001.
5
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report.
Lancet Oncol. 2012 Jan;13(1):e11-22. doi: 10.1016/S1470-2045(11)70175-9. Epub 2011 Oct 31.
7
8
Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma.
Surg Oncol. 2012 Jun;21(2):95-101. doi: 10.1016/j.suronc.2011.01.005. Epub 2011 Mar 11.
9
Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.
J Clin Oncol. 2010 Sep 1;28(25):3994-4005. doi: 10.1200/JCO.2010.28.7805. Epub 2010 Aug 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验